Resultados de la búsqueda 231-240 of 21485 for Treatment
Linvoseltamab has previously been studied as a single agent (without other cancer treatments) in participants with multiple myeloma that returned after prior ...
A Study To Compare Linvoseltamab And Daratumumab Treatment In High-Risk Smoldering Multiple Myeloma (HR-SMM) ... Rochester, Minn., Scottsdale/Phoenix, Ariz. This ...
... treatment or patients that are experiencing an upper digestive disease in order to standardize and validate outcome measures. Data will be used to establish ...
The goal of this clinical research study is to learn how often breast cancer recurs (returns after treatment) in the breast in patients who have been ...
Giving rituximab together with romidepsin and lenalidomide may be a better treatment for B-cell non-Hodgkin lymphoma. A Study To Evaluate Regulation Of The ...
Pheochromocytoma and paraganglioma treatment (PDQ) — Patient version. National Cancer Institute. https://www.cancer.gov/types/pheochromocytoma/patient/ ...
Giardiasis: Treatment and prevention. https://www.uptodate.com/contents/search. Accessed Nov. 3, 2020. Síntomas y causas · Enfermedades y afecciones. Infección ...
... treatment, while rates of disease control during Induction have not improved in recent COG trials. The current phase 3 trial seeks to improve the event-free ...
Detectar de inmediato los síntomas de un accidente cerebrovascular acorta el tiempo de tratamientos y reduce el daño causado al cerebro.
Treatment Of Metastatic Soft Tissue Sarcoma (STS) Patients (FIBROSARC USA). Scottsdale/Phoenix, Ariz., Jacksonville, Fla., Rochester, Minn. The present study is ...
Mayo Clinic no respalda compañías ni productos. Las recaudaciones de los avisos comerciales financian nuestra misión sin fines de lucro.
Consulta estos éxitos de venta y ofertas especiales en libros y boletines informativos de Mayo Clinic Press.
¿Te gustaría hacer una donación deducible de impuestos y ser parte de una investigación de vanguardia y de una atención médica que transforma la medicina?